Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and connectivity solutions. In 1995, Masimo debuted SET Measure-through Motion and Low Perfusion pulse oximetry, estimated to be used on more than 100 million patients annually. In 2005, Masimo introduced rainbow Pulse CO-Oximetry, allowing noninvasive and continuous monitoring of additional physiologic parameters that previously could only be measured invasively, such as total hemoglobin (SpHb). We continue to advance noninvasive monitoring, connectivity, and automation with innovations like the Root patient monitoring and connectivity hub and the Patient SafetyNet supplemental remote monitoring solution.
To learn more or update your cookie preferences, see our disclaimer page.